Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged ...

In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem cells to generate a continuous supply of functional T cells, the immune ...

Millions of people around the world are affected by retinal degenerative diseases. In most cases, loss of vision is caused by damage to the macula, a region in the center of the retina. The macula is ...

For many, it’s the ultimate dream – one which, with an exciting and controversial new gene therapy, is about to be put to the ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Researchers at Tianjin First Central Hospital took fat cells from the woman who had been living with Type 1 diabetes for over ...

In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem cells to generate a continuous supply of functional T cells, the immune ...

A mature cell of one type can be turned into a mature cell of another type without the cell having to pass through an earlier stage of development. This is called direct reprogramming, a reliable but ...

A team led by researchers at the University of Toronto has discovered that a group of cells located in the skin and other areas of the body, called neural crest stem cells, are the source of ...

The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...

Researchers in Japan have developed a form of stem cell therapy that "reverses" paralysis. Though the treatment has only seen a 50% success rate so far, two of the four people who received it have ...